Scherr, M., Elder, A., Battmer, K., Barzan, D., Bomken, S., Ricke-Hoch, M., . . . Eder, M. (2014). Differential expression of miR-17∼92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia. Nature Publishing Group.
Chicago-стиль цитированияScherr, M., et al. Differential Expression of MiR-17∼92 Identifies BCL2 As a Therapeutic Target in BCR-ABL-positive B-lineage Acute Lymphoblastic Leukemia. Nature Publishing Group, 2014.
MLA-цитированиеScherr, M., et al. Differential Expression of MiR-17∼92 Identifies BCL2 As a Therapeutic Target in BCR-ABL-positive B-lineage Acute Lymphoblastic Leukemia. Nature Publishing Group, 2014.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.